Ishikawa Endometrial Cancer Cells (Ishikawa)

The Ishikawa cell line is a well-established and widely studied human endometrial adenocarcinoma cell line that has been instrumental in advancing research in the fields of gynecologic oncology, hormone signaling, and reproductive biology. Originally derived from the endometrial tissue of a 39-year-old female patient with adenocarcinoma, the Ishikawa cell line serves as a valuable tool for investigating the molecular mechanisms underlying endometrial cancer development and progression.

Research using the Ishikawa cell line has provided important insights into the biology of endometrial cancer, including the roles of estrogen and progesterone signaling pathways, genetic alterations, and potential therapeutic vulnerabilities in this disease. Studies utilizing the Ishikawa cell line have also contributed to the identification of novel biomarkers, drug targets, and treatment strategies for endometrial cancer patients, with the goal of improving outcomes and personalized care.